SynthesisFrontiers in medicine2025
Epidemiology and burden of alopecia areata in Taiwan: a systematic review.
Synthesis in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Burden, Trends, Associated Diseases and Predictions of Alopecia Areata in China, Japan, South Korea, and Globally: A GBD 2023 Analysis.Clinical, cosmetic and investigational dermatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Alopecia areata (AA) is a common autoimmune disorder characterized by nonscarring hair loss on the scalp and/or body, affecting individuals of all genders, ages, and races. AA can occur alongside various autoimmune, atopic, and psychiatric conditions, affecting patients' quality of life. Although AA is a relatively common condition, recent epidemiological data regarding this condition in Taiwan are lacking. Methods: This systematic literature review aimed to assess the epidemiology, risk factors, and comorbidities associated with AA in Taiwan by analyzing articles published from January 2010 to June 2024. Results: A total of 37 studies were included, with most using the National Health Insurance Research Database (NHIRD) as the data source. The annual incidence and prevalence of AA in Taiwan were estimated at 0.011 and 0.014-0.016%, respectively. The mean age of AA onset ranged from 32 to 41.2 years, with a slight male predominance. Identified risk factors included autoimmune diseases, psychiatric disorders, viral infections, and lifestyle habits, while associated comorbidities involved chronic inflammatory dermatoses, atopic diseases, autoimmune diseases and mental disorders. Discussion: The review also highlighted evidence gaps, such as the need for validated diagnostic criteria in NHIRD and more research on ocular and systemic comorbidities. Given the significant disease burden of AA, further studies are needed to improve understanding and inform patient care and treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.